Behçet disease (CNS manifestations)

Changed by Bruno Di Muzio, 26 Apr 2015

Updates to Article Attributes

Body was changed:

CNS manifestations of Behçet disease (or, also known as neuro-Behçet disease) is one of the more, correspond to a common manifestations ofinvolvement related to systemicBehçet disease and has a variety of manifestations. 

For a discussion of the disease in general please refer to Behçet disease article. 

Epidemiology

CNS involvement is seen in 4-49% of patients with systemic Behçet disease, and has the same predilection of patients of middle eastern and Japanese descent 1

Clinical presentation

In the vast majority of cases, ulcerative lesions preceded neurological involvement, aiding in the diagnosis. In 3% of cases central nervous system manifestations occur first, making diagnosis significantly more challenging 1. Signs and symtomssymptoms include 1:

  • headaches
  • sensory disturbances
  • personality changes
  • dysarthria
  • cerebellar signs

Pathology

Neuro-Behçet disease, depending on the stage or degree of the inflammation, shows a perivascular infiltration of leukocytes and microglia, degeneration of oligodendroglia, and perivascular softening or necrosis 3.

Radiographic features

Unfortunately, neuro-Behçet disease has a wide variety of manifestations in the central nervous system, including 1

Meningoencephalitis and cerebral vein thrombosis are are discussed separately in general articles related to these conditions

MRI

Neuro: Behçet disease typically involves 1,3, in order of preference

  • brainstem: most common
  • basal ganglia: bilateral in a third of cases
  • brainstem
  • thalamus
  • subcortical white matter: less common
  • spinal cord: less common

Lesions of Behçet disease typically demonstrate the following signal characteristics 1:

  • T1: usually hypo-intense
  • T2:
    • usually hyperintense
    • associated with vasogenic oedema
    • in acute phase lesions cause mass effect 
  • T1 C+ (Gd): typically moderate patchy enhancement
  • DWI: isointense to slightly hyperintense [Ed: T2 shine through or true restricted diffusion?]

Treatment and prognosis

  • corticosteroids: i.v. methlyprednisolonemethylprednisolone infusion then oral prednisone 
  • immunosuppression: azathioprine, methotrexate, and anti TNFα

Differential diagnosis

Consider other causes of T2 hyperintensity of the basal ganglia

  • -<p><strong>CNS manifestations of Behçet</strong> <strong>disease</strong> (or <strong>neuro-Behçet disease</strong>) is one of the more common manifestations of systemic<a href="/articles/behcet-disease-2"> Behçet disease </a>and has a variety of manifestations. </p><p>For a discussion of the disease in general please refer to<a href="/articles/behcet-disease-2"> Behçet disease </a>article. </p><h4>Epidemiology</h4><p>CNS involvement is seen in 4-49% of patients with systemic <a href="/articles/behcet-disease-2">Behçet disease</a>, and has the same predilection of patients of middle eastern and Japanese descent <sup>1</sup>. </p><h4>Clinical presentation</h4><p>In the vast majority of cases, ulcerative lesions preceded neurological involvement, aiding in the diagnosis. In 3% of cases central nervous system manifestations occur first, making diagnosis significantly more challenging <sup>1</sup>. Signs and symtoms include <sup>1</sup>:</p><ul>
  • +<p><strong>CNS manifestations of Behçet</strong> <strong>disease</strong>, also known as <strong>neuro-Behçet disease</strong>, correspond to a common involvement related to systemic <a href="/articles/behcet-disease-2">Behçet disease</a> and has a variety of manifestations. </p><p>For a discussion of the disease in general please refer to<a href="/articles/behcet-disease-2"> Behçet disease </a>article. </p><h4>Epidemiology</h4><p>CNS involvement is seen in 4-49% of patients with systemic <a href="/articles/behcet-disease-2">Behçet disease</a>, and has the same predilection of patients of middle eastern and Japanese descent <sup>1</sup>. </p><h4>Clinical presentation</h4><p>In the vast majority of cases, ulcerative lesions preceded neurological involvement, aiding in the diagnosis. In 3% of cases central nervous system manifestations occur first, making diagnosis significantly more challenging <sup>1</sup>. Signs and symptoms include <sup>1</sup>:</p><ul>
  • -</ul><h4>Radiographic features</h4><p>Unfortunately, neuro-Behçet disease has a wide variety of manifestations in the central nervous system, including <sup>1</sup>: </p><ul>
  • +</ul><h4>Pathology</h4><p>Neuro-Behçet disease, depending on the stage or degree of the inflammation, shows a perivascular infiltration of leukocytes and microglia, degeneration of oligodendroglia, and perivascular softening or necrosis <sup>3</sup>.</p><h4>Radiographic features</h4><p>Unfortunately, neuro-Behçet disease has a wide variety of manifestations in the central nervous system, including <sup>1</sup>: </p><ul>
  • -</ul><p>Meningoencephalitis and cerebral vein thrombosis are discussed separately. </p><h5>MRI</h5><p>Neuro: Behçet disease typically involves <sup>1</sup>: </p><ul>
  • +</ul><p>Meningoencephalitis and cerebral vein thrombosis are discussed separately in general articles related to these conditions. </p><h5>MRI</h5><p>Neuro: Behçet disease typically involves <sup>1,3</sup>, in order of preference: </p><ul>
  • +<li>brainstem: most common</li>
  • -<li>brainstem</li>
  • -<li>thalamus</li>
  • +<li><span style="line-height:1.6">thalamus</span></li>
  • -<strong>T2:</strong><ul>
  • +<strong>T2</strong><ul>
  • -<li>corticosteroids: i.v. methlyprednisolone infusion then oral prednisone </li>
  • +<li>corticosteroids: i.v. methylprednisolone infusion then oral prednisone </li>
  • -</ul><p> </p><h4>Differential diagnosis</h4><ul>
  • +</ul><h4>Differential diagnosis</h4><ul>

References changed:

  • 3. Matsuo K, Yamada K, Nakajima K, Nakagawa M. Neuro-Behçet Disease Mimicking Brain Tumor. AJNR Am J Neuroradiol. 2005;26(3):650-3. <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7976491">PMC7976491</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/15760881">Pubmed</a>

ADVERTISEMENT: Supporters see fewer/no ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.